✦ LIBER ✦

Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients : A prospective, randomized, placebo-controlled phase 2 study

✍ Scribed by Yuichiro Hiura; Shuji Takiguchi; Kazuyoshi Yamamoto; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Hiroshi Miyata; Yoshiyuki Fujiwara; Masaki Mori; Kenji Kangawa; Yuichiro Doki

Book ID: 112067093
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 426 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.27430

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Maintenance Sunitinib Versus Placebo After Chemotherapy for Patients with Advanced Urothelial Carcinoma: Scientific Rationale and Study Design

✍ Deborah A. Bradley; Rodney Dunn; David Nanus; Walter Stadler; Robert Dreicer; Jo 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 106 KB

Prospective randomized controlled study

Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer

✍ Y. Kawahara; I. Ninomiya; T. Fujimura; H. Funaki; H. Nakagawara; H. Takamura; K. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 777 KB

Intravenous aflibercept for treatment of

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study

✍ Walter H Gotlieb; Frederic Amant; Suresh Advani; Chanchal Goswami; Hal Hirte; Di 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 196 KB

Neuroprotection with amifostine in the f

Neuroprotection with amifostine in the first-line treatment of advanced ovarian cancer with carboplatin/paclitaxel-based chemotherapy—a double-blind, placebo-controlled, randomized phase II study from the Arbeitsgemeinschaft Gynäkologische Onkologoie (AGO) Ovarian Cancer Study Group

✍ F. Hilpert; A. Stähle; O. Tomé; A. Burges; D. Rossner; K. Späthe; V. Heilmann; B 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 185 KB

38 Influence of amifostine on neuroprote

38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group

✍ P. Wimberger; R. Kimmig; F. Hilpert; A. Stähle; A. Burges; O. Tomé; D. Rossner; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 327 KB

The effects of oral zinc sulphate during

The effects of oral zinc sulphate during radiotherapy on anti-oxidant enzyme activities in patients with head and neck cancer: A prospective, randomised, placebo-controlled study

✍ M.V. Ertekin; M. Koç; I. Karslioǧlu; O. Sezen; S. Taysi; N. Bakan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB